Delivery Order SPE2DB22D3019-SPE2DB24FK3UM

Award Date 8/26/24
Potential Completion Date 8/27/24
Potential Value $26K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product. The order has a ceiling value of $2,164.12 and a period of performance through August 27, 2024. It is placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which provides a broad range of medical commodities to support military treatment programs...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of UBRELVY 50 MG TABLET UD 10S. The contract has a ceiling value of $1,411.72 and a completion date of September 17, 2024. This appears to be a delivery order placed against a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of UBRELVY 100 MG TABLET UD 10S. The $14,246.47 firm-fixed-price contract has an ultimate completion date of August 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA Troop Support Medical to efficiently procure a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of UBRELVY 100 MG TABLET UD 10S. The contract has a ceiling value of $9,399.75 and is a firm fixed-price delivery order without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product, with a total ceiling value of $3,206.81. The contract has an ultimate completion date of June 3, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of UBRELVY 100 mg tablets and has a total ceiling value of $1,949.28. The award date is September 4, 2024, and the ultimate completion date is September 5, 2024. The contract is a firm fixed-price type and does not have a set-aside designation. This award is likely part of a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of UBRELVY 50 MG TABLET UD 10S medication. The contract has a firm fixed price of $13,040.90 and a completion date of May 27, 2025. The order is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of UBRELVY 100 MG TABLET UD 16S. The contract has a ceiling value of $1,415.02 and is a firm fixed price delivery order with a completion date of June 17, 2025. The contract is not set aside and allows for the supply of brand-name and generic pharmaceutical products to support federal medical procurement needs, particularly for military and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of UBRELVY 100 MG TABLET UD 10S. The contract has a firm fixed price of $6,478.56 and a completion date of June 10, 2025. This contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen Drug Corp and DLA Troop Support Medical, valued at $999,999,999.00. The IDC provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The $1,399.88 firm fixed price contract is for the delivery of UBRELVY 50 MG TABLET UD 10S, a medication. The contract has a period of performance through March 14, 2024 and does not have a set-aside designation. This delivery order is issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug...
  • SPE2DB22D3019
    Indefinite Delivery Contract
  • SPE2DB22D3019-SPE2DB24FK3UM
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of UBRELVY 100 MG TABLET UD 16S, a pharmaceutical product. The award has a ceiling value of $25,981.48 and an ultimate completion date of August 27, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the supply of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/25/24, 9:03 AM